Loading insider details...
Latest Form 4 (Oct 26, 2026): Grant/Award of 13,307 LYCA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 26, 2026 | Lycia Therapeutics, Inc. (LYCA) | Grant/Award | 13,307 | n/a |
| Sep 11, 2026 | AtaiBeckley Inc. (ATAI) | Disposition to Issuer | 206,000 | n/a |
| Jun 18, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/Award | 3,772 | n/a |
| Jun 9, 2026 | AtaiBeckley Inc. (ATAI) | Grant/Award | 121,968 | n/a |
| Jun 2, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 3,977 | n/a |
| Dec 10, 2025 | Adverum Biotechnologies, Inc. (ADVM) | Exercise/Conversion | 150,000 | $630.0K |
| Dec 9, 2025 | Adverum Biotechnologies, Inc. (ADVM) | Purchase | 11,085 | $47.0K |
| Jun 27, 2025 | ATAI Life Sciences N.V. (ATAI) | Grant/Award | 103,000 | n/a |
| Jun 20, 2025 | Adverum Biotechnologies, Inc. (ADVM) | Disposition to Issuer | 120,000 | n/a |
| Jun 2, 2025 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/Award | 6,268 | n/a |